The gut microbiome plays a pivotal role in maintaining human health, with numerous studies
demonstrating that alterations in microbial compositions can significantly affect the …

Alzheimer's disease (AD) is the most common cause of dementia and accounts for 60–70%
of all cases. It affects millions of people worldwide. AD poses a substantial economic burden …

Mitochondrial dysfunction is an early pathological feature of Alzheimer disease and plays a
crucial role in the development and progression of Alzheimer's disease. Strategies to rescue …

Antiamyloid therapies for Alzheimer disease recently entered clinical practice, making
imaging biomarkers for Alzheimer disease even more relevant to guiding patient …

A hallmark of Alzheimer's disease (AD) are the proteinaceous aggregates formed by the
amyloid-beta peptide (Aβ) that is deposited inside the brain as amyloid plaques. The …

Alzheimer's disease (AD) is the most prevalent neurodegenerative dementia, marked by
progressive cognitive decline and memory impairment. Despite advances in therapeutic …

Background Dementia preventive interventions targeting multiple modifiable risk factors are
a promising approach. However, the impact of modifiable risk factors in the presence of beta …

Amyloid‐related imaging abnormalities, were originally described by dementia care experts.
The wider use of aducanumab and now lecanemab warrant broader understanding by the …

Alzheimer's disease, a progressive neurodegenerative condition, is characterized by a
gradual decline in cognitive functions. Current treatment approaches primarily involve the …

Despite Alzheimer's disease (AD) disproportionately affecting women, the mechanisms
remain elusive. In AD, microglia undergo 'metabolic reprogramming', which contributes to …